Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients With Skin of Color and Moderate-to-Severe Atopic Dermatitis
SKIN The Journal of Cutaneous Medicine · 10.11.2026 · 10 (6) · s830
DOI: 10.25251/y8xdwr35 ↗Kurz gefasst
Fachartikel in der Zeitschrift SKIN The Journal of Cutaneous Medicine, online erschienen am 10.11.2026. Verfasst von Andrew Alexis und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Dyspigmentation and xerosis are clinical manifestations in patients with skin of color (SoC) and atopic dermatitis (AD) that have not been well studied. We report the effect of dupilumab on dyspigmentation and xerosis in patients with SoC and AD.
Methods
DISCOVER (NCT05590585) was a phase 4, open-label, single arm, 24-week dupilumab study in patients ≥12 years old, with Fitzpatrick skin types (FST) IV/V/VI, and moderate-to-severe AD. Self-reported White/Caucasian patients were ineligible. Patients received dupilumab monotherapy q2w for 24 weeks (≥30−
Zitieren
APA
Alexis, A., Markowitz, O., Mayo, T., Callender, V., Levit, N., Xia, C., Chuang, C., Shumel, B., Wang, Z., & Hartford, C. (2026). Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients With Skin of Color and Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine, 10(6), s830. https://doi.org/10.25251/y8xdwr35
Vancouver
Alexis A, Markowitz O, Mayo T, Callender V, Levit N, Xia C, et al. Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients With Skin of Color and Moderate-to-Severe Atopic Dermatitis. SKIN The Journal of Cutaneous Medicine. 2026;10(6):s830. doi:10.25251/y8xdwr35
BibTeX
@article{Alexis2026,
author = {Alexis, Andrew and Markowitz, Orit and Mayo, Tiffany and Callender, Valerie and Levit, Noah and Xia, Changming and Chuang, Chien-Chia and Shumel, Brad and Wang, Zhixiao and Hartford, Christopher},
title = {Dupilumab Monotherapy Improves Xerosis and Dyspigmentation in Patients With Skin of Color and Moderate-to-Severe Atopic Dermatitis},
journal = {SKIN The Journal of Cutaneous Medicine},
year = {2026},
volume = {10},
number = {6},
pages = {s830},
doi = {10.25251/y8xdwr35}
}
EUVIMED